Toppgene analysis for Wikipedia protein communities, toppgene analysis, cc212_7, positive side

Go To Start Page
Input Parameters [Show Detail]
Training Results [Expand All] [Download All] [Sparse Matrix]
Display pValues and Scores as Table row limit

1: GO: Molecular Function [Display Chart] 7 input genes in category / 42 annotations before applied cutoff / 18661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0000980 RNA polymerase II distal enhancer sequence-specific DNA binding 2.961E-4 6.918E-3 2.993E-2 1.243E-2 2 71
2 GO:0016275 [cytochrome c]-arginine N-methyltransferase activity 3.751E-4 6.918E-3 2.993E-2 1.575E-2 1 1
3 GO:0001158 enhancer sequence-specific DNA binding 5.077E-4 6.918E-3 2.993E-2 2.132E-2 2 93
4 GO:0035326 enhancer binding 6.589E-4 6.918E-3 2.993E-2 2.767E-2 2 106
5 GO:0030519 snoRNP binding 1.125E-3 8.222E-3 3.557E-2 4.725E-2 1 3
6 GO:0044020 histone methyltransferase activity (H4-R3 specific) 1.500E-3 8.222E-3 3.557E-2
6.299E-2
 1 4
7 GO:0035241 protein-arginine omega-N monomethyltransferase activity 1.500E-3 8.222E-3 3.557E-2
6.299E-2
 1 4
8 GO:0001047 core promoter binding 1.566E-3 8.222E-3 3.557E-2
6.578E-2
 2 164
9 GO:0051525 NFAT protein binding 1.874E-3 8.747E-3 3.785E-2
7.872E-2
 1 5
10 GO:0048273 mitogen-activated protein kinase p38 binding 2.249E-3 9.445E-3 4.087E-2
9.445E-2
 1 6
11 GO:0035242 protein-arginine omega-N asymmetric methyltransferase activity 2.623E-3 1.002E-2 4.334E-2
1.102E-1
 1 7
12 GO:0008469 histone-arginine N-methyltransferase activity 2.998E-3 1.049E-2 4.539E-2
1.259E-1
 1 8
13 GO:0008140 cAMP response element binding protein binding 3.746E-3 1.155E-2 4.996E-2
1.573E-1
 1 10
14 GO:0001077 proximal promoter DNA-binding transcription activator activity, RNA polymerase II-specific 3.849E-3 1.155E-2 4.996E-2
1.616E-1
 2 259
15 GO:0043522 leucine zipper domain binding 4.867E-3 1.363E-2
5.896E-2
2.044E-1
 1 13
16 GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific 7.192E-3 1.727E-2
7.473E-2
3.021E-1
 2 357
17 GO:0030275 LRR domain binding 7.479E-3 1.727E-2
7.473E-2
3.141E-1
 1 20
18 GO:0000982 transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding 7.508E-3 1.727E-2
7.473E-2
3.153E-1
 2 365
19 GO:0000978 RNA polymerase II proximal promoter sequence-specific DNA binding 8.075E-3 1.727E-2
7.473E-2
3.392E-1
 2 379
20 GO:0008327 methyl-CpG binding 8.225E-3 1.727E-2
7.473E-2
3.454E-1
 1 22
21 GO:0000987 proximal promoter sequence-specific DNA binding 8.876E-3 1.775E-2
7.681E-2
3.728E-1
 2 398
22 GO:0051019 mitogen-activated protein kinase binding 1.120E-2 2.045E-2
8.850E-2
4.704E-1
 1 30
23 GO:0001205 distal enhancer DNA-binding transcription activator activity, RNA polymerase II-specific 1.120E-2 2.045E-2
8.850E-2
4.704E-1
 1 30
24 GO:0042054 histone methyltransferase activity 2.193E-2 3.837E-2
1.660E-1
9.209E-1
 1 59
25 GO:0000979 RNA polymerase II core promoter sequence-specific DNA binding 2.450E-2 4.076E-2
1.764E-1
1.000E0
 1 66
26 GO:0003725 double-stranded RNA binding 2.523E-2 4.076E-2
1.764E-1
1.000E0
 1 68
27 GO:0016273 arginine N-methyltransferase activity 3.182E-2 4.773E-2
2.065E-1
1.000E0
 1 86
28 GO:0016274 protein-arginine N-methyltransferase activity 3.182E-2 4.773E-2
2.065E-1
1.000E0
 1 86
Show 23 more annotations

2: GO: Biological Process [Display Chart] 7 input genes in category / 326 annotations before applied cutoff / 18623 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0045646 regulation of erythrocyte differentiation 8.915E-5 1.702E-2
1.083E-1
 2.906E-2 2 39
2 GO:0043414 macromolecule methylation 1.044E-4 1.702E-2
1.083E-1
 3.404E-2 3 273
3 GO:0032259 methylation 2.160E-4 1.787E-2
1.138E-1
7.040E-2
 3 349
4 GO:2001244 positive regulation of intrinsic apoptotic signaling pathway 2.193E-4 1.787E-2
1.138E-1
7.149E-2
 2 61
5 GO:0016570 histone modification 4.474E-4 2.678E-2
1.705E-1
1.459E-1
 3 447
6 GO:0016569 covalent chromatin modification 4.929E-4 2.678E-2
1.705E-1
1.607E-1
 3 462
7 GO:0030218 erythrocyte differentiation 7.513E-4 2.721E-2
1.732E-1
2.449E-1
 2 113
8 GO:0044324 regulation of transcription involved in anterior/posterior axis specification 7.516E-4 2.721E-2
1.732E-1
2.450E-1
 1 2
9 GO:2000016 negative regulation of determination of dorsal identity 7.516E-4 2.721E-2
1.732E-1
2.450E-1
 1 2
10 GO:0034101 erythrocyte homeostasis 8.892E-4 2.721E-2
1.732E-1
2.899E-1
 2 123
11 GO:0046985 positive regulation of hemoglobin biosynthetic process 1.127E-3 2.721E-2
1.732E-1
3.675E-1
 1 3
12 GO:0002262 myeloid cell homeostasis 1.301E-3 2.721E-2
1.732E-1
4.240E-1
 2 149
13 GO:2001242 regulation of intrinsic apoptotic signaling pathway 1.497E-3 2.721E-2
1.732E-1
4.882E-1
 2 160
14 GO:0044027 hypermethylation of CpG island 1.503E-3 2.721E-2
1.732E-1
4.899E-1
 1 4
15 GO:0008213 protein alkylation 1.767E-3 2.721E-2
1.732E-1
5.762E-1
 2 174
16 GO:0006479 protein methylation 1.767E-3 2.721E-2
1.732E-1
5.762E-1
 2 174
17 GO:0002244 hematopoietic progenitor cell differentiation 1.788E-3 2.721E-2
1.732E-1
5.827E-1
 2 175
18 GO:2000015 regulation of determination of dorsal identity 1.878E-3 2.721E-2
1.732E-1
6.123E-1
 1 5
19 GO:0044026 DNA hypermethylation 1.878E-3 2.721E-2
1.732E-1
6.123E-1
 1 5
20 GO:0046984 regulation of hemoglobin biosynthetic process 1.878E-3 2.721E-2
1.732E-1
6.123E-1
 1 5
21 GO:1903026 negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding 1.878E-3 2.721E-2
1.732E-1
6.123E-1
 1 5
22 GO:2001235 positive regulation of apoptotic signaling pathway 2.168E-3 2.721E-2
1.732E-1
7.069E-1
 2 193
23 GO:0045347 negative regulation of MHC class II biosynthetic process 2.253E-3 2.721E-2
1.732E-1
7.346E-1
 1 6
24 GO:0043985 histone H4-R3 methylation 2.253E-3 2.721E-2
1.732E-1
7.346E-1
 1 6
25 GO:0032792 negative regulation of CREB transcription factor activity 2.253E-3 2.721E-2
1.732E-1
7.346E-1
 1 6
26 GO:1902262 apoptotic process involved in blood vessel morphogenesis 2.253E-3 2.721E-2
1.732E-1
7.346E-1
 1 6
27 GO:0090241 negative regulation of histone H4 acetylation 2.253E-3 2.721E-2
1.732E-1
7.346E-1
 1 6
28 GO:0045637 regulation of myeloid cell differentiation 2.442E-3 2.764E-2
1.760E-1
7.960E-1
 2 205
29 GO:0045876 positive regulation of sister chromatid cohesion 2.629E-3 2.764E-2
1.760E-1
8.569E-1
 1 7
30 GO:1902177 positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway 2.629E-3 2.764E-2
1.760E-1
8.569E-1
 1 7
31 GO:0019919 peptidyl-arginine methylation, to asymmetrical-dimethyl arginine 2.629E-3 2.764E-2
1.760E-1
8.569E-1
 1 7
32 GO:1903025 regulation of RNA polymerase II regulatory region sequence-specific DNA binding 3.004E-3 2.880E-2
1.833E-1
9.792E-1
 1 8
33 GO:0001955 blood vessel maturation 3.004E-3 2.880E-2
1.833E-1
9.792E-1
 1 8
34 GO:0035247 peptidyl-arginine omega-N-methylation 3.004E-3 2.880E-2
1.833E-1
9.792E-1
 1 8
35 GO:0007050 cell cycle arrest 3.521E-3 3.191E-2
2.031E-1
1.000E0
 2 247
36 GO:0036500 ATF6-mediated unfolded protein response 3.753E-3 3.191E-2
2.031E-1
1.000E0
 1 10
37 GO:0035246 peptidyl-arginine N-methylation 3.753E-3 3.191E-2
2.031E-1
1.000E0
 1 10
38 GO:0090068 positive regulation of cell cycle process 3.864E-3 3.191E-2
2.031E-1
1.000E0
 2 259
39 GO:0006983 ER overload response 4.128E-3 3.191E-2
2.031E-1
1.000E0
 1 11
40 GO:1902237 positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway 4.128E-3 3.191E-2
2.031E-1
1.000E0
 1 11
41 GO:0048872 homeostasis of number of cells 4.407E-3 3.191E-2
2.031E-1
1.000E0
 2 277
42 GO:0048263 determination of dorsal identity 4.503E-3 3.191E-2
2.031E-1
1.000E0
 1 12
43 GO:0042541 hemoglobin biosynthetic process 4.503E-3 3.191E-2
2.031E-1
1.000E0
 1 12
44 GO:0034969 histone arginine methylation 4.503E-3 3.191E-2
2.031E-1
1.000E0
 1 12
45 GO:0090239 regulation of histone H4 acetylation 4.503E-3 3.191E-2
2.031E-1
1.000E0
 1 12
46 GO:0048262 determination of dorsal/ventral asymmetry 4.503E-3 3.191E-2
2.031E-1
1.000E0
 1 12
47 GO:1990440 positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress 4.877E-3 3.230E-2
2.056E-1
1.000E0
 1 13
48 GO:1903209 positive regulation of oxidative stress-induced cell death 4.877E-3 3.230E-2
2.056E-1
1.000E0
 1 13
49 GO:0097193 intrinsic apoptotic signaling pathway 5.182E-3 3.230E-2
2.056E-1
1.000E0
 2 301
50 GO:0033044 regulation of chromosome organization 5.182E-3 3.230E-2
2.056E-1
1.000E0
 2 301
Show 45 more annotations

3: GO: Cellular Component [Display Chart] 7 input genes in category / 17 annotations before applied cutoff / 19061 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0005667 transcription factor complex 2.358E-4 2.497E-3 8.588E-3 4.009E-3 3 368
2 GO:0035976 transcription factor AP-1 complex 3.672E-4 2.497E-3 8.588E-3 6.243E-3 1 1
3 GO:0090575 RNA polymerase II transcription factor complex 6.199E-4 2.497E-3 8.588E-3 1.054E-2 2 105
4 GO:1990622 CHOP-ATF3 complex 7.344E-4 2.497E-3 8.588E-3 1.248E-2 1 2
5 GO:1990617 CHOP-ATF4 complex 7.344E-4 2.497E-3 8.588E-3 1.248E-2 1 2
6 GO:0044798 nuclear transcription factor complex 1.007E-3 2.675E-3 9.200E-3 1.711E-2 2 134
7 GO:0036488 CHOP-C/EBP complex 1.101E-3 2.675E-3 9.200E-3 1.872E-2 1 3
8 GO:0042382 paraspeckles 2.202E-3 4.679E-3 1.609E-2 3.743E-2 1 6
9 GO:0034709 methylosome 4.399E-3 8.310E-3 2.858E-2
7.479E-2
 1 12
10 GO:0000785 chromatin 1.256E-2 2.136E-2
7.346E-2
2.136E-1
 2 487
Show 5 more annotations

4: Human Phenotype [Display Chart] 3 input genes in category / 148 annotations before applied cutoff / 4707 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 HP:0006765 Chondrosarcoma 3.141E-7 2.324E-5 1.296E-4 4.649E-5 3 33
2 HP:0006741 Increased risk of malignancy 3.141E-7 2.324E-5 1.296E-4 4.649E-5 3 33
3 HP:0006779 Alveolar rhabdomyosarcoma 5.133E-5 2.105E-3 1.174E-2 7.597E-3 2 20
4 HP:0010622 Neoplasm of the skeletal system 5.689E-5 2.105E-3 1.174E-2 8.420E-3 3 182
5 HP:0100244 Fibrosarcoma 2.209E-4 6.538E-3 3.647E-2 3.269E-2 2 41
6 HP:0100242 Sarcoma 7.058E-4 1.741E-2
9.711E-2
1.045E-1
 3 420
7 HP:0002859 Rhabdomyosarcoma 1.119E-3 1.744E-2
9.725E-2
1.657E-1
 2 92
8 HP:0100243 Leiomyosarcoma 1.219E-3 1.744E-2
9.725E-2
1.804E-1
 2 96
9 HP:0012268 Myxoid liposarcoma 1.274E-3 1.744E-2
9.725E-2
1.886E-1
 1 2
10 HP:0012034 Liposarcoma 1.274E-3 1.744E-2
9.725E-2
1.886E-1
 1 2
11 HP:0009728 Neoplasm of striated muscle 1.296E-3 1.744E-2
9.725E-2
1.918E-1
 2 99
12 HP:0002579 Gastrointestinal dysmotility 1.657E-3 1.887E-2
1.053E-1
2.453E-1
 2 112
13 HP:0030895 Abnormal gastrointestinal motility 1.657E-3 1.887E-2
1.053E-1
2.453E-1
 2 112
14 HP:0006717 Peripheral neuroepithelioma 3.184E-3 3.323E-2
1.854E-1
4.712E-1
 1 5
15 HP:0004808 Acute myeloid leukemia 3.368E-3 3.323E-2
1.854E-1
4.985E-1
 2 160
16 HP:0012254 Ewing sarcoma 3.820E-3 3.534E-2
1.971E-1
5.654E-1
 1 6
17 HP:0003270 Abdominal distention 4.636E-3 4.036E-2
2.251E-1
6.861E-1
 2 188
Show 12 more annotations

5: Mouse Phenotype [Display Chart] 5 input genes in category / 251 annotations before applied cutoff / 10355 genes in category

No results to display

6: Domain [Display Chart] 7 input genes in category / 46 annotations before applied cutoff / 18735 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 4.10.1060.10 - Gene3D 5.377E-6 2.474E-4 1.092E-3 2.474E-4 2 10
2 PF00641 zf-RanBP Pfam 2.754E-5 2.741E-4 1.211E-3 1.267E-3 2 22
3 PS50199 ZF RANBP2 2 PROSITE 3.016E-5 2.741E-4 1.211E-3 1.387E-3 2 23
4 SM00547 ZnF RBZ SMART 3.016E-5 2.741E-4 1.211E-3 1.387E-3 2 23
5 PS01358 ZF RANBP2 1 PROSITE 3.290E-5 2.741E-4 1.211E-3 1.513E-3 2 24
6 IPR001876 Znf RanBP2 InterPro 3.575E-5 2.741E-4 1.211E-3 1.645E-3 2 25
7 PF00076 RRM 1 Pfam 4.568E-5 2.835E-4 1.252E-3 2.101E-3 3 208
8 SM00360 RRM SMART 5.183E-5 2.835E-4 1.252E-3 2.384E-3 3 217
9 IPR000504 RRM dom InterPro 5.927E-5 2.835E-4 1.252E-3 2.727E-3 3 227
10 PS50102 RRM PROSITE 6.163E-5 2.835E-4 1.252E-3 2.835E-3 3 230
11 3.30.70.330 - Gene3D 7.348E-5 3.073E-4 1.357E-3 3.380E-3 3 244
12 IPR012677 Nucleotide-bd a/b plait InterPro 8.673E-5 3.325E-4 1.468E-3 3.989E-3 3 258
13 IPR033109 EWSR1 InterPro 3.736E-4 1.146E-3 5.061E-3 1.719E-2 1 1
14 IPR033099 ILF3/NF90 InterPro 3.736E-4 1.146E-3 5.061E-3 1.719E-2 1 1
15 IPR016670 DNA damage induc transcript 3 InterPro 3.736E-4 1.146E-3 5.061E-3 1.719E-2 1 1
16 IPR012975 NOPS InterPro 1.121E-3 3.032E-3 1.339E-2
5.154E-2
 1 3
17 PF08075 NOPS Pfam 1.121E-3 3.032E-3 1.339E-2
5.154E-2
 1 3
18 IPR006561 DZF dom InterPro 1.867E-3 4.090E-3 1.806E-2
8.588E-2
 1 5
19 PF07528 DZF Pfam 1.867E-3 4.090E-3 1.806E-2
8.588E-2
 1 5
20 SM00572 DZF SMART 1.867E-3 4.090E-3 1.806E-2
8.588E-2
 1 5
21 PS51703 DZF PROSITE 1.867E-3 4.090E-3 1.806E-2
8.588E-2
 1 5
22 IPR025799 Arg MeTrfase InterPro 3.358E-3 6.717E-3 2.967E-2
1.545E-1
 1 9
23 PS51678 SAM MT PRMT PROSITE 3.358E-3 6.717E-3 2.967E-2
1.545E-1
 1 9
24 PF07716 bZIP 2 Pfam 6.335E-3 1.214E-2
5.363E-2
2.914E-1
 1 17
25 SM00358 DSRM SMART 7.079E-3 1.302E-2
5.753E-2
3.256E-1
 1 19
26 PF00035 dsrm Pfam 7.450E-3 1.318E-2
5.821E-2
3.427E-1
 1 20
27 PS50137 DS RBD PROSITE 7.821E-3 1.332E-2
5.885E-2
3.598E-1
 1 21
28 3.30.160.20 - Gene3D 1.005E-2 1.369E-2
6.047E-2
4.621E-1
 1 27
29 PS00345 ETS DOMAIN 1 PROSITE 1.042E-2 1.369E-2
6.047E-2
4.792E-1
 1 28
30 IPR014720 dsRBD dom InterPro 1.042E-2 1.369E-2
6.047E-2
4.792E-1
 1 28
31 IPR000418 Ets dom InterPro 1.042E-2 1.369E-2
6.047E-2
4.792E-1
 1 28
32 SM00413 ETS SMART 1.042E-2 1.369E-2
6.047E-2
4.792E-1
 1 28
33 PS00346 ETS DOMAIN 2 PROSITE 1.042E-2 1.369E-2
6.047E-2
4.792E-1
 1 28
34 PF00178 Ets Pfam 1.042E-2 1.369E-2
6.047E-2
4.792E-1
 1 28
35 PS50061 ETS DOMAIN 3 PROSITE 1.042E-2 1.369E-2
6.047E-2
4.792E-1
 1 28
36 IPR000637 HMGI/Y DNA-bd CS InterPro 1.153E-2 1.473E-2
6.505E-2
5.302E-1
 1 31
37 SM00338 BRLZ SMART 1.927E-2 2.301E-2
1.016E-1
8.865E-1
 1 52
38 PS00036 BZIP BASIC PROSITE 1.964E-2 2.301E-2
1.016E-1
9.034E-1
 1 53
39 PS50217 BZIP PROSITE 1.964E-2 2.301E-2
1.016E-1
9.034E-1
 1 53
40 IPR004827 bZIP InterPro 2.001E-2 2.301E-2
1.016E-1
9.203E-1
 1 54
41 IPR000048 IQ motif EF-hand-BS InterPro 3.315E-2 3.719E-2
1.643E-1
1.000E0
 1 90
42 PS50096 IQ PROSITE 3.424E-2 3.750E-2
1.656E-1
1.000E0
 1 93
43 3.40.50.150 - Gene3D 4.399E-2 4.674E-2
2.064E-1
1.000E0
 1 120
44 IPR029063 SAM-dependent MTases InterPro 4.471E-2 4.674E-2
2.064E-1
1.000E0
 1 122
Show 39 more annotations

7: Pathway [Display Chart] 6 input genes in category / 47 annotations before applied cutoff / 12450 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 523016 Transcriptional misregulation in cancer BioSystems: KEGG 6.198E-7 2.913E-5 1.293E-4 2.913E-5 4 180
2 169353 Validated targets of C-MYC transcriptional repression BioSystems: Pathway Interaction Database 3.498E-4 8.219E-3 3.648E-2 1.644E-2 2 61
3 PW:0000142 ubiquinone biosynthetic Pathway Ontology 9.637E-4 1.510E-2
6.700E-2
 4.529E-2 1 2
4 PW:0000078 cyanoamino acid metabolic Pathway Ontology 1.445E-3 1.698E-2
7.536E-2
6.792E-2
 1 3
5 1383030 PTK6 Regulates Proteins Involved in RNA Processing BioSystems: REACTOME 2.408E-3 2.263E-2
1.004E-1
1.132E-1
 1 5
6 PW:0000133 selenoamino acid metabolic Pathway Ontology 3.850E-3 2.937E-2
1.304E-1
1.810E-1
 1 8
7 1268758 ATF6 (ATF6-alpha) activates chaperone genes BioSystems: REACTOME 5.291E-3 2.937E-2
1.304E-1
2.487E-1
 1 11
8 PW:0000040 androgen and estrogen metabolic Pathway Ontology 5.291E-3 2.937E-2
1.304E-1
2.487E-1
 1 11
9 PW:0000051 histidine metabolic Pathway Ontology 5.770E-3 2.937E-2
1.304E-1
2.712E-1
 1 12
10 1268757 ATF6 (ATF6-alpha) activates chaperones BioSystems: REACTOME 6.250E-3 2.937E-2
1.304E-1
2.937E-1
 1 13
11 PW:0000052 tyrosine metabolic Pathway Ontology 7.688E-3 3.285E-2
1.458E-1
3.613E-1
 1 16
12 PW:0000398 homocysteine metabolic Pathway Ontology 8.645E-3 3.299E-2
1.464E-1
4.063E-1
 1 18
13 1383073 TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest BioSystems: REACTOME 9.124E-3 3.299E-2
1.464E-1
4.288E-1
 1 19
14 PW:0000054 tryptophan metabolic Pathway Ontology 1.104E-2 3.705E-2
1.644E-1
5.187E-1
 1 23
15 PW:0000048 methionine cycle/metabolic Pathway Ontology 1.199E-2 3.753E-2
1.666E-1
5.635E-1
 1 25
16 1268762 ATF4 activates genes BioSystems: REACTOME 1.294E-2 3.753E-2
1.666E-1
6.084E-1
 1 27
17 137959 BARD1 signaling events BioSystems: Pathway Interaction Database 1.390E-2 3.753E-2
1.666E-1
6.532E-1
 1 29
18 1268761 PERK regulates gene expression BioSystems: REACTOME 1.437E-2 3.753E-2
1.666E-1
6.756E-1
 1 30
19 138012 Signaling mediated by p38-alpha and p38-beta BioSystems: Pathway Interaction Database 1.675E-2 4.144E-2
1.839E-1
7.874E-1
 1 35
20 M862 p38 MAPK Signaling Pathway MSigDB C2 BIOCARTA (v6.0) 1.913E-2 4.495E-2
1.995E-1
8.990E-1
 1 40
21 83038 Basal transcription factors BioSystems: KEGG 2.150E-2 4.693E-2
2.083E-1
1.000E0
 1 45
22 P00046 Oxidative stress response PantherDB 2.197E-2 4.693E-2
2.083E-1
1.000E0
 1 46
23 1383071 TP53 Regulates Transcription of Cell Cycle Genes BioSystems: REACTOME 2.339E-2 4.779E-2
2.121E-1
1.000E0
 1 49
24 138006 ATF-2 transcription factor network BioSystems: Pathway Interaction Database 2.622E-2 4.825E-2
2.141E-1
1.000E0
 1 55
25 83117 Acute myeloid leukemia BioSystems: KEGG 2.622E-2 4.825E-2
2.141E-1
1.000E0
 1 55
26 137916 Regulation of retinoblastoma protein BioSystems: Pathway Interaction Database 2.669E-2 4.825E-2
2.141E-1
1.000E0
 1 56
Show 21 more annotations

8: Pubmed [Display Chart] 7 input genes in category / 1862 annotations before applied cutoff / 38193 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 15782174 Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. Pubmed 1.080E-11 2.011E-8 1.631E-7 2.011E-8 4 30
2 25324306 hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling. Pubmed 1.227E-9 1.142E-6 9.258E-6 2.284E-6 5 346
3 26831064 CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly. Pubmed 7.293E-9 3.996E-6 3.240E-5 1.358E-5 5 494
4 28225217 Proteomic analysis of the cullin 4B interactome using proximity-dependent biotinylation in living cells. Pubmed 8.585E-9 3.996E-6 3.240E-5 1.598E-5 4 153
5 22570737 Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells. Pubmed 2.879E-8 4.468E-6 3.622E-5 5.361E-5 2 2
6 11422378 Characterization of a new brain-specific isoform of the EWS oncoprotein. Pubmed 2.879E-8 4.468E-6 3.622E-5 5.361E-5 2 2
7 22454397 Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Pubmed 2.879E-8 4.468E-6 3.622E-5 5.361E-5 2 2
8 19124016 PRMT1 mediated methylation of TAF15 is required for its positive gene regulatory function. Pubmed 2.879E-8 4.468E-6 3.622E-5 5.361E-5 2 2
9 29193371 Differential interaction of PRMT1 with RGG-boxes of the FET family proteins EWS and TAF15. Pubmed 2.879E-8 4.468E-6 3.622E-5 5.361E-5 2 2
10 8954779 Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins. Pubmed 2.879E-8 4.468E-6 3.622E-5 5.361E-5 2 2
11 10749851 Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3. Pubmed 2.879E-8 4.468E-6 3.622E-5 5.361E-5 2 2
12 17647282 Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion. Pubmed 2.879E-8 4.468E-6 3.622E-5 5.361E-5 2 2
13 23975937 A conserved N-terminal motif is required for complex formation between FUS, EWSR1, TAF15 and their oncogenic fusion proteins. Pubmed 8.637E-8 8.041E-6 6.519E-5 1.608E-4 2 3
14 27415968 Role of FET proteins in neurodegenerative disorders. Pubmed 8.637E-8 8.041E-6 6.519E-5 1.608E-4 2 3
15 21344536 mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma. Pubmed 8.637E-8 8.041E-6 6.519E-5 1.608E-4 2 3
16 21856723 FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Pubmed 8.637E-8 8.041E-6 6.519E-5 1.608E-4 2 3
17 27311318 Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis. Pubmed 8.637E-8 8.041E-6 6.519E-5 1.608E-4 2 3
18 18620564 The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. Pubmed 8.637E-8 8.041E-6 6.519E-5 1.608E-4 2 3
19 23049996 Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions. Pubmed 8.637E-8 8.041E-6 6.519E-5 1.608E-4 2 3
20 12359745 Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. Pubmed 8.637E-8 8.041E-6 6.519E-5 1.608E-4 2 3
21 16033648 A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain. Pubmed 1.044E-7 9.257E-6 7.505E-5 1.944E-4 4 285
22 9660765 The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription. Pubmed 1.727E-7 1.340E-5 1.086E-4 3.216E-4 2 4
23 28453628 Post-transcriptional regulation of FUS and EWS protein expression by miR-141 during neural differentiation. Pubmed 1.727E-7 1.340E-5 1.086E-4 3.216E-4 2 4
24 12704081 Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1. Pubmed 1.727E-7 1.340E-5 1.086E-4 3.216E-4 2 4
25 24332808 PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry. Pubmed 2.115E-7 1.575E-5 1.277E-4 3.937E-4 4 340
26 16051612 PRMT8, a new membrane-bound tissue-specific member of the protein arginine methyltransferase family. Pubmed 2.879E-7 1.914E-5 1.552E-4 5.360E-4 2 5
27 18316480 Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Pubmed 2.879E-7 1.914E-5 1.552E-4 5.360E-4 2 5
28 26766589 Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia. Pubmed 2.879E-7 1.914E-5 1.552E-4 5.360E-4 2 5
29 19135240 Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. Pubmed 3.569E-7 2.292E-5 1.858E-4 6.646E-4 3 84
30 18509338 Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Pubmed 4.318E-7 2.680E-5 2.172E-4 8.039E-4 2 6
31 15635413 Nucleolar proteome dynamics. Pubmed 4.869E-7 2.925E-5 2.371E-4 9.066E-4 4 419
32 12183049 Identification of methylated proteins by protein arginine N-methyltransferase 1, PRMT1, with a new expression cloning strategy. Pubmed 8.058E-7 4.689E-5 3.801E-4 1.500E-3 2 8
33 11850402 PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays. Pubmed 1.036E-6 5.845E-5 4.739E-4 1.929E-3 2 9
34 9488465 EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Pubmed 1.295E-6 7.091E-5 5.749E-4 2.411E-3 2 10
35 26336360 Beads-free protein immunoprecipitation for a mass spectrometry-based interactome and posttranslational modifications analysis. Pubmed 2.312E-6 1.230E-4 9.969E-4 4.304E-3 3 156
36 22751105 Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress. Pubmed 2.448E-6 1.266E-4 1.026E-3 4.558E-3 3 159
37 25756610 DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. Pubmed 3.265E-6 1.643E-4 1.332E-3 6.080E-3 3 175
38 22174317 Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production. Pubmed 5.327E-6 2.610E-4 2.116E-3 9.918E-3 3 206
39 23463506 The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. Pubmed 5.806E-6 2.772E-4 2.247E-3 1.081E-2 3 212
40 28431233 A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. Pubmed 9.975E-6 4.634E-4 3.757E-3 1.857E-2 3 254
41 15324660 Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Pubmed 1.021E-5 4.634E-4 3.757E-3 1.901E-2 3 256
42 21081666 Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. Pubmed 1.045E-5 4.634E-4 3.757E-3 1.946E-2 3 258
43 18239623 Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPalpha. Pubmed 1.166E-5 5.050E-4 4.094E-3 2.172E-2 2 29
44 19542561 Proline-rich sequence recognition: II. Proteomics analysis of Tsg101 ubiquitin-E2-like variant (UEV) interactions. Pubmed 1.424E-5 6.028E-4 4.887E-3 2.652E-2 2 32
45 24147044 Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activator. Pubmed 1.809E-5 6.627E-4 5.372E-3 3.368E-2 2 36
46 17620599 Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Pubmed 1.934E-5 6.627E-4 5.372E-3 3.601E-2 3 317
47 19928837 The SMN interactome includes Myb-binding protein 1a. Pubmed 2.969E-5 6.627E-4 5.372E-3
5.528E-2
 2 46
48 25147182 Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1. Pubmed 3.698E-5 6.627E-4 5.372E-3
6.885E-2
 3 394
49 21319273 An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Pubmed 3.782E-5 6.627E-4 5.372E-3
7.043E-2
 3 397
50 24591637 Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. Pubmed 3.801E-5 6.627E-4 5.372E-3
7.078E-2
 2 52
Show 45 more annotations

9: Interaction [Display Chart] 7 input genes in category / 1319 annotations before applied cutoff / 17703 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 int:FUS FUS interactions 1.164E-9 1.536E-6 1.192E-5 1.536E-6 6 419
2 int:SF1 SF1 interactions 1.524E-7 1.005E-4 7.803E-4 2.011E-4 4 146
3 int:PRMT8 PRMT8 interactions 3.439E-7 1.362E-4 1.057E-3 4.536E-4 3 39
4 int:RPS6KB2 RPS6KB2 interactions 5.388E-7 1.362E-4 1.057E-3 7.107E-4 4 200
5 int:CEBPA CEBPA interactions 6.803E-7 1.362E-4 1.057E-3 8.973E-4 4 212
6 int:PRMT1 PRMT1 interactions 1.062E-6 1.362E-4 1.057E-3 1.401E-3 4 237
7 int:MIR9-3 MIR9-3 interactions 1.794E-6 1.362E-4 1.057E-3 2.366E-3 3 67
8 int:MIR138-1 MIR138-1 interactions 1.876E-6 1.362E-4 1.057E-3 2.475E-3 3 68
9 int:MIR29B2 MIR29B2 interactions 2.139E-6 1.362E-4 1.057E-3 2.821E-3 3 71
10 int:MIR122 MIR122 interactions 2.139E-6 1.362E-4 1.057E-3 2.821E-3 3 71
11 int:MIR29B1 MIR29B1 interactions 2.327E-6 1.362E-4 1.057E-3 3.069E-3 3 73
12 int:MIR20A MIR20A interactions 2.425E-6 1.362E-4 1.057E-3 3.198E-3 3 74
13 int:MIR15A MIR15A interactions 2.425E-6 1.362E-4 1.057E-3 3.198E-3 3 74
14 int:MIR16-1 MIR16-1 interactions 2.425E-6 1.362E-4 1.057E-3 3.198E-3 3 74
15 int:MIR222 MIR222 interactions 2.629E-6 1.362E-4 1.057E-3 3.467E-3 3 76
16 int:MIR7-3 MIR7-3 interactions 2.629E-6 1.362E-4 1.057E-3 3.467E-3 3 76
17 int:MIR199A2 MIR199A2 interactions 2.629E-6 1.362E-4 1.057E-3 3.467E-3 3 76
18 int:MIR200A MIR200A interactions 2.735E-6 1.362E-4 1.057E-3 3.607E-3 3 77
19 int:MIR451A MIR451A interactions 2.735E-6 1.362E-4 1.057E-3 3.607E-3 3 77
20 int:MIR92A1 MIR92A1 interactions 2.735E-6 1.362E-4 1.057E-3 3.607E-3 3 77
21 int:MIR9-2 MIR9-2 interactions 2.735E-6 1.362E-4 1.057E-3 3.607E-3 3 77
22 int:MIR1-2 MIR1-2 interactions 2.955E-6 1.362E-4 1.057E-3 3.898E-3 3 79
23 int:MIR34C MIR34C interactions 2.955E-6 1.362E-4 1.057E-3 3.898E-3 3 79
24 int:MIR206 MIR206 interactions 2.955E-6 1.362E-4 1.057E-3 3.898E-3 3 79
25 int:MIR143 MIR143 interactions 3.070E-6 1.362E-4 1.057E-3 4.049E-3 3 80
26 int:MIR145 MIR145 interactions 3.070E-6 1.362E-4 1.057E-3 4.049E-3 3 80
27 int:MIR10B MIR10B interactions 3.188E-6 1.362E-4 1.057E-3 4.204E-3 3 81
28 int:MIR106A MIR106A interactions 3.431E-6 1.362E-4 1.057E-3 4.526E-3 3 83
29 int:MIR107 MIR107 interactions 3.558E-6 1.362E-4 1.057E-3 4.693E-3 3 84
30 int:MIR200B MIR200B interactions 3.558E-6 1.362E-4 1.057E-3 4.693E-3 3 84
31 int:MIR199A1 MIR199A1 interactions 3.558E-6 1.362E-4 1.057E-3 4.693E-3 3 84
32 int:MIR16-2 MIR16-2 interactions 3.558E-6 1.362E-4 1.057E-3 4.693E-3 3 84
33 int:MIR17 MIR17 interactions 3.688E-6 1.362E-4 1.057E-3 4.864E-3 3 85
34 int:MIR9-1 MIR9-1 interactions 3.688E-6 1.362E-4 1.057E-3 4.864E-3 3 85
35 int:MIR18B MIR18B interactions 3.688E-6 1.362E-4 1.057E-3 4.864E-3 3 85
36 int:MIR29A MIR29A interactions 3.820E-6 1.362E-4 1.057E-3 5.039E-3 3 86
37 int:MIR20B MIR20B interactions 3.820E-6 1.362E-4 1.057E-3 5.039E-3 3 86
38 int:MIR29C MIR29C interactions 4.095E-6 1.363E-4 1.058E-3 5.401E-3 3 88
39 int:MIR141 MIR141 interactions 4.095E-6 1.363E-4 1.058E-3 5.401E-3 3 88
40 int:MIR92A2 MIR92A2 interactions 4.237E-6 1.363E-4 1.058E-3 5.589E-3 3 89
41 int:MIR221 MIR221 interactions 4.237E-6 1.363E-4 1.058E-3 5.589E-3 3 89
42 int:MIR1-1 MIR1-1 interactions 4.382E-6 1.376E-4 1.068E-3 5.780E-3 3 90
43 int:MIR155 MIR155 interactions 4.683E-6 1.403E-4 1.089E-3 6.177E-3 3 92
44 int:MIR128-1 MIR128-1 interactions 4.683E-6 1.403E-4 1.089E-3 6.177E-3 3 92
45 int:MIRLET7F1 MIRLET7F1 interactions 4.997E-6 1.403E-4 1.089E-3 6.591E-3 3 94
46 int:MIR19B2 MIR19B2 interactions 4.997E-6 1.403E-4 1.089E-3 6.591E-3 3 94
47 int:SUZ12 SUZ12 interactions 5.306E-6 1.403E-4 1.089E-3 6.998E-3 4 355
48 int:MIRLET7F2 MIRLET7F2 interactions 5.324E-6 1.403E-4 1.089E-3 7.023E-3 3 96
49 int:MIRLET7A2 MIRLET7A2 interactions 5.324E-6 1.403E-4 1.089E-3 7.023E-3 3 96
50 int:MIR363 MIR363 interactions 5.324E-6 1.403E-4 1.089E-3 7.023E-3 3 96
Show 45 more annotations

10: Cytoband [Display Chart] 7 input genes in category / 7 annotations before applied cutoff / 34661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 17q11.1-q11.2 17q11.1-q11.2 2.020E-4 7.068E-4 1.833E-3 1.414E-3 1 1
2 12q13.1-q13.2 12q13.1-q13.2 2.020E-4 7.068E-4 1.833E-3 1.414E-3 1 1
3 22q12.2 22q12.2 1.206E-2 2.058E-2
5.336E-2
8.439E-2
 1 60
4 1p34.3 1p34.3 1.325E-2 2.058E-2
5.336E-2
9.278E-2
 1 66
5 19q13.3 19q13.3 1.684E-2 2.058E-2
5.336E-2
1.179E-1
 1 84
6 11p11.2 11p11.2 1.764E-2 2.058E-2
5.336E-2
1.235E-1
 1 88
7 19p13.2 19p13.2 4.651E-2 4.651E-2
1.206E-1
3.256E-1
 1 235
Show 2 more annotations

11: Transcription Factor Binding Site [Display Chart] 6 input genes in category / 114 annotations before applied cutoff / 9770 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 ACAWNRNSRCGG UNKNOWN ACAWNRNSRCGG UNKNOWN 4.434E-4 2.643E-2
1.405E-1
5.055E-2
 2 54
2 RRCCGTTA UNKNOWN RRCCGTTA UNKNOWN 5.476E-4 2.643E-2
1.405E-1
6.243E-2
 2 60
3 GCCATNTTG V$YY1 Q6 GCCATNTTG V$YY1 Q6 6.954E-4 2.643E-2
1.405E-1
7.928E-2
 3 328
4 KCCGNSWTTT UNKNOWN KCCGNSWTTT UNKNOWN 1.202E-3 3.426E-2
1.822E-1
1.370E-1
 2 89

12: Gene Family [Display Chart] 5 input genes in category / 5 annotations before applied cutoff / 18194 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 89 Zinc fingers RANBP2-type genenames.org 1.266E-5 3.888E-5 8.877E-5 6.331E-5 2 21
2 725 RNA binding motif containing genenames.org 1.555E-5 3.888E-5 8.877E-5 7.775E-5 3 213
3 691 Protein arginine methyltransferases genenames.org 2.471E-3 4.119E-3 9.404E-3 1.236E-2 1 9
4 534 ETS transcription factor family genenames.org 7.672E-3 9.590E-3 2.190E-2 3.836E-2 1 28
5 694 Protein phosphatase 1 regulatory subunits genenames.org 4.877E-2 4.877E-2
1.114E-1
2.438E-1
 1 181

13: Coexpression [Display Chart] 7 input genes in category / 896 annotations before applied cutoff / 23137 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M9150 Genes from common genomic gains observed in a meta analyis of copy number alterations across a panel of different cancer cell lines and tumor samples. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.262E-6 9.102E-4 6.713E-3 1.131E-3 4 323
2 14993899-TableS1 Human Futreal04 427genes ConsensusCancerGenes GeneSigDB 2.032E-6 9.102E-4 6.713E-3 1.820E-3 4 364
3 M5901 Genes involved in the G2/M checkpoint, as in progression through the cell division cycle. MSigDB H: Hallmark Gene Sets (v6.0) 2.171E-5 6.484E-3 4.782E-2 1.945E-2 3 200
4 M14278 Cluster 5: genes up-regulated in B493-6 cells (B lymphocytes) by MYC [GeneID=4609] alone or in combination with serum but not by serum alone. MSigDB C2: CGP Curated Gene Sets (v6.0) 8.427E-5 1.661E-2
1.225E-1
7.550E-2
 2 47
5 M13936 Genes down-regulated in BJAB cells (B-lymphoma) after glutamine [PubChem=738] deprivation. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.026E-4 1.661E-2
1.225E-1
9.197E-2
 3 337
6 18172295-SuppTable4 Human Bone Heller08 693genes GeneSigDB 1.248E-4 1.661E-2
1.225E-1
1.118E-1
 3 360
7 M3958 Genes most significantly up-regulated in multiple myeloma samples, compared to normal bone marrow plasma cells. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.568E-4 1.661E-2
1.225E-1
1.405E-1
 2 64
8 11861292-Table5 Human BoneMarrow Zhan02 69genes GeneSigDB 1.568E-4 1.661E-2
1.225E-1
1.405E-1
 2 64
9 M5275 Genes up-regulated in blood samples from bladder cancer patients. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.756E-4 1.661E-2
1.225E-1
1.573E-1
 3 404
10 M6897 Genes up-regulated in T98 cells (glioma) 48 h after treatment with interferon beta. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.930E-4 1.661E-2
1.225E-1
1.730E-1
 2 71
11 M15150 Genes up-regulated in cancer stem cells isolated from mammary tumors compared to the non-tumorigenic cells. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.039E-4 1.661E-2
1.225E-1
1.827E-1
 3 425
12 M1613 Transcripts depleted in pseudopodia of NIH/3T3 cells (fibroblast) in response to the chemotactic migration stimulus by lysophosphatidic acid (LPA) [PubChem=3988]. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.526E-4 1.820E-2
1.343E-1
2.263E-1
 3 457
13 15489886-TableS1b Human Sarcoma Mason04 549genes GeneSigDB 2.641E-4 1.820E-2
1.343E-1
2.367E-1
 3 464
14 18535662-TableS1b Mouse Lymphoma Wu08 1114genes GeneSigDB 3.195E-4 2.045E-2
1.508E-1
2.863E-1
 3 495
15 19805619-TableS3 Mouse Leukemia Powell09 138genes GeneSigDB 5.508E-4 2.615E-2
1.928E-1
4.935E-1
 2 120
16 M8512 Genes up-regulated in TK6, WTK1, and NH32 cell lines (lymphoblast) in response to ionizing radiation. MSigDB C2: CGP Curated Gene Sets (v6.0) 8.470E-4 2.615E-2
1.928E-1
7.589E-1
 2 149
17 M6822 Genes down-regulated in HMLE cells (mmortalized nontransformed mammary epithelial) by expression of a dominant-negative form of E-cadhedrin (CDH1) [GeneID=999]. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.087E-3 2.615E-2
1.928E-1
9.742E-1
 2 169
18 20068086-ST1-5 Human Breast Lee10 184genes GeneSigDB 1.100E-3 2.615E-2
1.928E-1
9.857E-1
 2 170
19 M2718 Genes up-regulated in MEF cells (embryonic fibroblasts) with knockout of SNF5 [Gene ID=6598] gene. MSigDB C6: Oncogenic Signatures (v6.0) 1.152E-3 2.615E-2
1.928E-1
1.000E0
 2 174
20 16239301-SuppTable2a Human Breast Harvell 194genes GeneSigDB 1.192E-3 2.615E-2
1.928E-1
1.000E0
 2 177
21 M8828 Genes up-regulated in hematopoietic stem cells versus lymphoid primed multipotent progenitors. MSigDB C7: Immunologic Signatures (v6.0) 1.192E-3 2.615E-2
1.928E-1
1.000E0
 2 177
22 M19988 Genes down-regulated in metastatic breast cancer tumors having type 2 amplification in the 20q13 region; involves MYBL2, STK6 and ZNF217 [GeneID=4605;6790;7764] MSigDB C2: CGP Curated Gene Sets (v6.0) 1.232E-3 2.615E-2
1.928E-1
1.000E0
 2 180
23 M12104 Genes down-regulated in BJAB cells (B-lymphoma) after leucine [PubChem=857] deprivation. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.329E-3 2.615E-2
1.928E-1
1.000E0
 2 187
24 M4404 Genes down-regulated in comparison of naive CD8 T cells versus naive CD4 [GeneID=920] T cells. MSigDB C7: Immunologic Signatures (v6.0) 1.502E-3 2.615E-2
1.928E-1
1.000E0
 2 199
25 M5102 Genes up-regulated in comparison of untreated CD8+ dendritic cells (DC) at 4 h versus those treated with IFNG [GeneID=3458] at 16 h. MSigDB C7: Immunologic Signatures (v6.0) 1.502E-3 2.615E-2
1.928E-1
1.000E0
 2 199
26 M3186 Genes down-regulated in comparison of IgD+ peripheral blood B cells versus IgD- naive tonsil B cells. MSigDB C7: Immunologic Signatures (v6.0) 1.502E-3 2.615E-2
1.928E-1
1.000E0
 2 199
27 M6010 Genes down-regulated in dendritic cells: wildtype versus I ab-/- mice. MSigDB C7: Immunologic Signatures (v6.0) 1.502E-3 2.615E-2
1.928E-1
1.000E0
 2 199
28 M6484 Genes up-regulated in monocyte-derived dendritic cells: untreated versus LPS and LPS like antigen from O. planktothrix (3h). MSigDB C7: Immunologic Signatures (v6.0) 1.502E-3 2.615E-2
1.928E-1
1.000E0
 2 199
29 M4928 Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 3 post-vaccination. MSigDB C7: Immunologic Signatures (v6.0) 1.502E-3 2.615E-2
1.928E-1
1.000E0
 2 199
30 M3171 Genes up-regulated in comparison of germinal center B cells versus memory B cells. MSigDB C7: Immunologic Signatures (v6.0) 1.502E-3 2.615E-2
1.928E-1
1.000E0
 2 199
31 M8444 Genes down-regulated in lung innate lymphoid cells versus spleen CD4 [GeneID=920] T cells. MSigDB C7: Immunologic Signatures (v6.0) 1.502E-3 2.615E-2
1.928E-1
1.000E0
 2 199
32 11165872-Table1 Human Breast Li01 5genes up MCF7 MnSOD GeneSigDB 1.512E-3 2.615E-2
1.928E-1
1.000E0
 1 5
33 M8331 Genes down-regulated in BCL6 [GeneID=604] high follicular helper T cells (Tfh) versus all Tfh. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
34 M8550 Genes up-regulated in CD8 T cells: KLRB1 high [GeneID=3820] versus KLRB1 int [GeneID=3820]. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
35 M3702 Genes down-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with LPS (TLR4 agonist) at 12 h. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
36 M7712 Genes up-regulated in bone marrow-derived dendritic cellstreated by poly(IC): 0h versus 6h. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
37 M5196 Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to T. gondii. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
38 M5364 Genes down-regulated in comparison of untreated eosinophils versus eosinophils treated with PMA [PubChem=4792] at 2 h. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
39 M5368 Genes down-regulated in comparison of untreated macrophages versus macrophages treated with LPS (TLR4 agonist) at 4 h. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
40 M8096 Genes down-regulated in spleen follicular B lymphocytes: wildtype versus IRF8 [GeneID=3394] knockout. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
41 M8218 Genes down-regulated in Pmel-1 CD8 T cells primed with cognate antigen: IL2 [GeneID=3558] versus IL-12. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
42 M4467 Genes down-regulated in comparison of neutrophils versusl monocytes. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
43 M8777 Genes down-regulated in dendritic cells: wildtype versus NLRP10 [GeneID=338322] knockout. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
44 M4360 Genes up-regulated in comparison of lung tissue from wild type mice subjected to ozone for 0 h versus that from wild type mice subjected to ozone for 6 h. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
45 M6587 Genes down-regulated in monocytes versus classically activated (M1) macrophages. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
46 M4473 Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated neutrophils. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
47 M3156 Genes up-regulated in comparison of T follicular helper (Tfh) cells versus Th17 cells. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
48 M4790 Genes up-regulated in comparison of lineage negative versus erythroblasts. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
49 M9643 Genes up-regulated in CD4 [GeneID=920] T helper cells (10h): Th0 versus TGFB1 and IL6 [GeneID=7040;3569]. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
50 M9022 Genes down-regulated in CD69- KRLG1- [GeneID=969;10219] T reg: SELL high [GeneID=6402] versus SELL low [GeneID=6402]. MSigDB C7: Immunologic Signatures (v6.0) 1.517E-3 2.615E-2
1.928E-1
1.000E0
 2 200
Show 45 more annotations

14: Coexpression Atlas [Display Chart] 7 input genes in category / 776 annotations before applied cutoff / 21829 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Mast cell/Kidney Tumour Wilms Mast cell/Kidney Tumour Wilms IN15 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Mast cell/Kidney Tumour Wilms Mast cell/Kidney Tumour Wilms IN15 Adult, Development, and Cancer types 2.031E-7 1.576E-4 1.140E-3 1.576E-4 4 193
2 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP RCC2/Kidney Normal fetal kidney MNP RCC2 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP RCC2/Kidney Normal fetal kidney MNP RCC2 Adult, Development, and Cancer types 2.012E-5 6.190E-3 4.476E-2 1.561E-2 3 184
3 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP1-like/Kidney Normal fetal kidney MNP1-like Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP1-like/Kidney Normal fetal kidney MNP1-like Adult, Development, and Cancer types 2.393E-5 6.190E-3 4.476E-2 1.857E-2 3 195
4 gudmap developingGonad e12.5 epididymis k1 1000 DevelopingGonad e12.5 epididymis emap-29139 k-means-cluster#1 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 5.708E-5 1.107E-2
8.008E-2
 4.429E-2 3 261
5 gudmap developingGonad e12.5 epididymis k2 500 DevelopingGonad e12.5 epididymis emap-29139 k-means-cluster#2 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 9.062E-5 1.406E-2
1.017E-1
7.032E-2
 2 46
6 gudmap developingKidney e15.5 ureter tip flank cortic collct 1000 k5 DevelopingKidney e15.5 ureter tip flank cortic collct emap-27752 k-means-cluster#5 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 1.241E-4 1.604E-2
1.160E-1
9.627E-2
 3 339
7 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney NK cell/Kidney Normal fetal kidney NK cell/Kidney Normal fetal kidney NK7 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney NK cell/Kidney Normal fetal kidney NK cell/Kidney Normal fetal kidney NK7 Adult, Development, and Cancer types 2.550E-4 2.827E-2
2.044E-1
1.979E-1
 2 77
8 gudmap developingGonad e11.5 testes k5 1000 DevelopingGonad e11.5 testes emap-3226 k-means-cluster#5 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 3.858E-4 3.607E-2
2.609E-1
2.994E-1
 3 498
9 gudmap developingGonad e14.5 epididymis 1000 k1 DevelopingGonad e14.5 epididymis emap-29141 k-means-cluster#1 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 4.213E-4 3.607E-2
2.609E-1
3.269E-1
 2 99
10 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Normal cell/Kidney Normal fetal kidney Normal cell Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Normal cell/Kidney Normal fetal kidney Normal cell Adult, Development, and Cancer types 4.648E-4 3.607E-2
2.609E-1
3.607E-1
 2 104
11 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney PT-U/Kidney Normal fetal kidney PT-U/Kidney Normal fetal kidney PT9 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney PT-U/Kidney Normal fetal kidney PT-U/Kidney Normal fetal kidney PT9 Adult, Development, and Cancer types 5.198E-4 3.667E-2
2.652E-1
4.034E-1
 2 110
12 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney EN-D/Kidney Normal-Cortex Wilms EN-D Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney EN-D/Kidney Normal-Cortex Wilms EN-D Adult, Development, and Cancer types 8.759E-4 4.005E-2
2.897E-1
6.797E-1
 2 143
13 Sample Type by Project: Shred 1/TCGA-Lung/Lung Carcinoma/Lung Adenocarcinoma Mixed Subtype/0/0 Sample Type by Project: Shred 1/TCGA-Lung/Lung Carcinoma/Lung Adenocarcinoma Mixed Subtype/0/0 TCGA-Lung 8.881E-4 4.005E-2
2.897E-1
6.891E-1
 2 144
14 gudmap developingGonad e12.5 ovary k4 1000 DevelopingGonad e12.5 ovary emap-28876 k-means-cluster#4 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 9.630E-4 4.005E-2
2.897E-1
7.473E-1
 2 150
15 gudmap developingGonad e11.5 ovary + mesonephros k4 1000 DevelopingGonad e11.5 ovary + mesonephros emap-3226 k-means-cluster#4 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 1.041E-3 4.005E-2
2.897E-1
8.077E-1
 2 156
16 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney NK cell/Kidney Normal fetal kidney NK cell Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney NK cell/Kidney Normal fetal kidney NK cell Adult, Development, and Cancer types 1.177E-3 4.005E-2
2.897E-1
9.136E-1
 2 166
17 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney U U/Kidney Normal VHL RCC U U/Kidney Normal VHL RCC U17 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney U U/Kidney Normal VHL RCC U U/Kidney Normal VHL RCC U17 Adult, Development, and Cancer types 1.352E-3 4.005E-2
2.897E-1
1.000E0
 2 178
18 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney IF-U/Kidney Normal-Medulla Wilms IF-U/Kidney Normal-Medulla Wilms IF10 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney IF-U/Kidney Normal-Medulla Wilms IF-U/Kidney Normal-Medulla Wilms IF10 Adult, Development, and Cancer types 1.428E-3 4.005E-2
2.897E-1
1.000E0
 2 183
19 Facebase RNAseq e10.5 Neural Epithelium Overlying Medial Eminence 1000 K3 FacebaseRNAseq e10.5 Neural Epithelium Overlying Medial Eminence top-relative-expression-ranked 1000 k-means-cluster#3 FaceBase_RNAseq 1.459E-3 4.005E-2
2.897E-1
1.000E0
 2 185
20 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephron epithelium/Kidney Normal fetal kidney Nephron epithelium/Kidney Normal fetal kidney PT1 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephron epithelium/Kidney Normal fetal kidney Nephron epithelium/Kidney Normal fetal kidney PT1 Adult, Development, and Cancer types 1.459E-3 4.005E-2
2.897E-1
1.000E0
 2 185
21 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Mural/Mural/Acta2/Acta2,Rgs5//Col3a1/Mural.Rgs5.Acta2.Col3a1/FrontalCortex BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Mural/Mural/Acta2/Acta2,Rgs5//Col3a1/Mural.Rgs5.Acta2.Col3a1/FrontalCortex BrainMap 1.522E-3 4.005E-2
2.897E-1
1.000E0
 2 189
22 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney EN-G/Kidney Normal fetal kidney EN-G Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney EN-G/Kidney Normal fetal kidney EN-G Adult, Development, and Cancer types 1.522E-3 4.005E-2
2.897E-1
1.000E0
 2 189
23 Human Kidney Development/Human Kidney Fetal Kidney Cell Atlas: (Tang et al 2018)/Human/Cell Subclass of Age of Cell Class of Tissue (subtype)/Podocyte (PD) Human Kidney Development/Human Kidney Fetal Kidney Cell Atlas: (Tang et al 2018)/Human/Cell Subclass of Age of Cell Class of Tissue (subtype)/Podocyte (PD) Fetal, Development 1.522E-3 4.005E-2
2.897E-1
1.000E0
 2 189
24 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Ureter IF-U/Ureter Normal RCC IF-U Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Ureter IF-U/Ureter Normal RCC IF-U Adult, Development, and Cancer types 1.538E-3 4.005E-2
2.897E-1
1.000E0
 2 190
25 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Ureter epithelium/Kidney Normal fetal kidney Ureter epithelium Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Ureter epithelium/Kidney Normal fetal kidney Ureter epithelium Adult, Development, and Cancer types 1.554E-3 4.005E-2
2.897E-1
1.000E0
 2 191
26 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Junk/Kidney Normal fetal kidney Junk Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Junk/Kidney Normal fetal kidney Junk Adult, Development, and Cancer types 1.554E-3 4.005E-2
2.897E-1
1.000E0
 2 191
27 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney NK cell/Kidney NephrogenicRest Wilms NK cell/Kidney NephrogenicRest Wilms NK2 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney NK cell/Kidney NephrogenicRest Wilms NK cell/Kidney NephrogenicRest Wilms NK2 Adult, Development, and Cancer types 1.586E-3 4.005E-2
2.897E-1
1.000E0
 2 193
28 Human Kidney Development/Human Kidney Fetal Kidney Cell Atlas: (Tang et al 2018)/Human/Cell Subclass of Age of Cell Class of Tissue (subtype)/Cap mesenchyme (CM)/early fetal/CM b Human Kidney Development/Human Kidney Fetal Kidney Cell Atlas: (Tang et al 2018)/Human/Cell Subclass of Age of Cell Class of Tissue (subtype)/Cap mesenchyme (CM)/early fetal/CM b Fetal, Development 1.602E-3 4.005E-2
2.897E-1
1.000E0
 1 5
29 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP2/Kidney Tumour VHL RCC MNP2 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP2/Kidney Tumour VHL RCC MNP2 Adult, Development, and Cancer types 1.619E-3 4.005E-2
2.897E-1
1.000E0
 2 195
30 Endothelial cells (ED)/Endothelial cells (ED) b Endothelial cells (ED)/Endothelial cells (ED) b 1.619E-3 4.005E-2
2.897E-1
1.000E0
 2 195
31 Mesangium (MG)/Mesangium (MG) a Mesangium (MG)/Mesangium (MG) a 1.635E-3 4.005E-2
2.897E-1
1.000E0
 2 196
32 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP RCC1/Kidney Normal fetal kidney MNP RCC1 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP RCC1/Kidney Normal fetal kidney MNP RCC1 Adult, Development, and Cancer types 1.652E-3 4.005E-2
2.897E-1
1.000E0
 2 197
33 gudmap developingGonad e11.5 testes k2 500 DevelopingGonad e11.5 testes emap-3226 k-means-cluster#2 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 1.753E-3 4.121E-2
2.980E-1
1.000E0
 2 203
Show 28 more annotations

15: Computational [Display Chart] 7 input genes in category / 91 annotations before applied cutoff / 10037 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M19542 MODULE 15 Genes in the cancer module 14. MSigDb: C4 - CM: Cancer Modules (v6.0) 5.115E-5 4.655E-3 2.371E-2 4.655E-3 4 358
2 M16765 MODULE 332 Genes in the cancer module 332. MSigDb: C4 - CM: Cancer Modules (v6.0) 4.069E-4 1.287E-2
6.553E-2
 3.703E-2 2 45
3 M4550 MODULE 252 TFs and nuclear. MSigDb: C4 - CM: Cancer Modules (v6.0) 4.241E-4 1.287E-2
6.553E-2
 3.860E-2 3 237
4 M17658 MODULE 198 Genes in the cancer module 198. MSigDb: C4 - CM: Cancer Modules (v6.0) 8.711E-4 1.982E-2
1.009E-1
7.927E-2
 3 303
5 M14843 MODULE 98 Genes in the cancer module 98. MSigDb: C4 - CM: Cancer Modules (v6.0) 1.854E-3 3.373E-2
1.718E-1
1.687E-1
 3 393

16: MicroRNA [Display Chart] 7 input genes in category / 195 annotations before applied cutoff / 72241 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 hsa-miR-1296-5p:Functional MTI Functional MTI miRTarbase 5.715E-5 1.114E-2
6.523E-2
 1.114E-2 2 120
2 hsa-miR-196a-5p:Functional MTI Functional MTI miRTarbase 3.631E-4 3.541E-2
2.072E-1
7.081E-2
 2 303
3 hsa-miR-149-5p:Functional MTI Functional MTI miRTarbase 6.212E-4 4.038E-2
2.363E-1
1.211E-1
 2 397
4 hsa-miR-10a-5p:Functional MTI Functional MTI miRTarbase 8.426E-4 4.108E-2
2.404E-1
1.643E-1
 2 463
5 hsa-miR-574-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.613E-3 4.483E-2
2.624E-1
5.096E-1
 1 27
6 hsa-miR-135a-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.483E-3 4.483E-2
2.624E-1
6.792E-1
 1 36
7 hsa-miR-1296:PITA hsa-miR-1296:PITA TOP PITA 3.870E-3 4.483E-2
2.624E-1
7.546E-1
 1 40
8 hsa-miR-4669:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.870E-3 4.483E-2
2.624E-1
7.546E-1
 1 40
9 hsa-miR-3657:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.966E-3 4.483E-2
2.624E-1
7.734E-1
 1 41
10 hsa-miR-5587-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.063E-3 4.483E-2
2.624E-1
7.922E-1
 1 42
11 TCTAGAG,MIR-517:MSigDB TCTAGAG,MIR-517:MSigDB MSigDB 4.159E-3 4.483E-2
2.624E-1
8.111E-1
 1 43
12 hsa-miR-4512:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.642E-3 4.483E-2
2.624E-1
9.052E-1
 1 48
13 hsa-miR-3135a:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.932E-3 4.483E-2
2.624E-1
9.617E-1
 1 51
14 hsa-miR-7160-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.221E-3 4.483E-2
2.624E-1
1.000E0
 1 54
15 hsa-miR-3914:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.414E-3 4.483E-2
2.624E-1
1.000E0
 1 56
16 hsa-miR-4258:mirSVR highEffct hsa-miR-4258:mirSVR nonconserved highEffect-0.5 MicroRNA.org 5.992E-3 4.483E-2
2.624E-1
1.000E0
 1 62
17 hsa-miR-362-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.089E-3 4.483E-2
2.624E-1
1.000E0
 1 63
18 hsa-miR-569:Functional MTI Functional MTI miRTarbase 6.185E-3 4.483E-2
2.624E-1
1.000E0
 1 64
19 hsa-miR-671-3p:mirSVR highEffct hsa-miR-671-3p:mirSVR nonconserved highEffect-0.5 MicroRNA.org 6.282E-3 4.483E-2
2.624E-1
1.000E0
 1 65
20 hsa-miR-5187-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.378E-3 4.483E-2
2.624E-1
1.000E0
 1 66
21 hsa-miR-590-5p:Functional MTI Functional MTI miRTarbase 6.378E-3 4.483E-2
2.624E-1
1.000E0
 1 66
22 hsa-miR-566:mirSVR highEffct hsa-miR-566:mirSVR nonconserved highEffect-0.5 MicroRNA.org 6.860E-3 4.483E-2
2.624E-1
1.000E0
 1 71
23 hsa-miR-4645-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.860E-3 4.483E-2
2.624E-1
1.000E0
 1 71
24 AAGGGAT,MIR-188:MSigDB AAGGGAT,MIR-188:MSigDB MSigDB 6.860E-3 4.483E-2
2.624E-1
1.000E0
 1 71
25 hsa-miR-7109-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 7.052E-3 4.483E-2
2.624E-1
1.000E0
 1 73
26 hsa-miR-6508-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 7.149E-3 4.483E-2
2.624E-1
1.000E0
 1 74
27 hsa-miR-4778-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 7.341E-3 4.483E-2
2.624E-1
1.000E0
 1 76
28 hsa-miR-1204:mirSVR highEffct hsa-miR-1204:mirSVR nonconserved highEffect-0.5 MicroRNA.org 7.823E-3 4.483E-2
2.624E-1
1.000E0
 1 81
29 hsa-miR-633:Functional MTI Functional MTI miRTarbase 7.823E-3 4.483E-2
2.624E-1
1.000E0
 1 81
30 hsa-miR-6895-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 8.015E-3 4.483E-2
2.624E-1
1.000E0
 1 83
31 hsa-miR-339-3p:mirSVR highEffct hsa-miR-339-3p:mirSVR nonconserved highEffect-0.5 MicroRNA.org 8.015E-3 4.483E-2
2.624E-1
1.000E0
 1 83
32 hsa-miR-6728-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 8.015E-3 4.483E-2
2.624E-1
1.000E0
 1 83
33 GGCAGTG,MIR-324-3P:MSigDB GGCAGTG,MIR-324-3P:MSigDB MSigDB 8.400E-3 4.483E-2
2.624E-1
1.000E0
 1 87
34 hsa-miR-6090:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 8.496E-3 4.483E-2
2.624E-1
1.000E0
 1 88
35 hsa-miR-7845-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 9.458E-3 4.483E-2
2.624E-1
1.000E0
 1 98
36 hsa-miR-1289:PITA hsa-miR-1289:PITA TOP PITA 9.458E-3 4.483E-2
2.624E-1
1.000E0
 1 98
37 ATAGGAA,MIR-202:MSigDB ATAGGAA,MIR-202:MSigDB MSigDB 9.554E-3 4.483E-2
2.624E-1
1.000E0
 1 99
38 hsa-miR-4285:mirSVR lowEffct hsa-miR-4285:mirSVR nonconserved lowEffect-0.1-0.5 MicroRNA.org 9.842E-3 4.483E-2
2.624E-1
1.000E0
 1 102
39 hsa-miR-509-3p:PITA hsa-miR-509-3p:PITA TOP PITA 9.938E-3 4.483E-2
2.624E-1
1.000E0
 1 103
40 hsa-miR-4314:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.003E-2 4.483E-2
2.624E-1
1.000E0
 1 104
41 hsa-miR-720:mirSVR highEffct hsa-miR-720:mirSVR nonconserved highEffect-0.5 MicroRNA.org 1.071E-2 4.483E-2
2.624E-1
1.000E0
 1 111
42 hsa-miR-383-5p:Functional MTI Functional MTI miRTarbase 1.080E-2 4.483E-2
2.624E-1
1.000E0
 1 112
43 hsa-miR-99a*:mirSVR highEffct hsa-miR-99a*:mirSVR nonconserved highEffect-0.5 MicroRNA.org 1.109E-2 4.483E-2
2.624E-1
1.000E0
 1 115
44 hsa-miR-6877-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.128E-2 4.483E-2
2.624E-1
1.000E0
 1 117
45 hsa-miR-220a:mirSVR highEffct hsa-miR-220a:mirSVR nonconserved highEffect-0.5 MicroRNA.org 1.138E-2 4.483E-2
2.624E-1
1.000E0
 1 118
46 hsa-miR-6819-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.147E-2 4.483E-2
2.624E-1
1.000E0
 1 119
47 hsa-miR-423-3p:mirSVR highEffct hsa-miR-423-3p:mirSVR nonconserved highEffect-0.5 MicroRNA.org 1.176E-2 4.483E-2
2.624E-1
1.000E0
 1 122
48 hsa-miR-5694:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.176E-2 4.483E-2
2.624E-1
1.000E0
 1 122
49 AGCATTA,MIR-155:MSigDB AGCATTA,MIR-155:MSigDB MSigDB 1.243E-2 4.483E-2
2.624E-1
1.000E0
 1 129
50 hsa-miR-99b*:mirSVR highEffct hsa-miR-99b*:mirSVR nonconserved highEffect-0.5 MicroRNA.org 1.253E-2 4.483E-2
2.624E-1
1.000E0
 1 130
Show 45 more annotations

17: Drug [Display Chart] 7 input genes in category / 2512 annotations before applied cutoff / 22841 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 CID006711154 DAPH2 Stitch 5.399E-7 1.356E-3 1.140E-2 1.356E-3 3 58
2 ctd:C495626 14-deoxy-11,12-didehydroandrographolide CTD 1.513E-5 1.273E-2
1.070E-1
 3.800E-2 3 175
3 1974 DN Pyrimethamine [58-14-0]; Down 200; 16uM; HL60; HG-U133A Broad Institute CMAP Down 1.935E-5 1.273E-2
1.070E-1
 4.860E-2 3 190
4 1380 DN Spironolactone [52-01-7]; Down 200; 9.6uM; HL60; HG-U133A Broad Institute CMAP Down 2.028E-5 1.273E-2
1.070E-1
5.094E-2
 3 193
5 CID000208772 A-skin Stitch 3.976E-5 1.882E-2
1.582E-1
9.987E-2
 2 32
6 CID005091655 EMCs Stitch 4.495E-5 1.882E-2
1.582E-1
1.129E-1
 2 34
7 CID006480473 AC1O59H4 Stitch 1.186E-4 3.054E-2
2.568E-1
2.980E-1
 2 55
8 CID006399012 NOR-1 Stitch 1.925E-4 3.054E-2
2.568E-1
4.836E-1
 2 70
9 ctd:D014042 Tolazamide CTD 3.065E-4 3.054E-2
2.568E-1
7.698E-1
 1 1
10 ctd:D000611 Aminobiphenyl Compounds CTD 3.065E-4 3.054E-2
2.568E-1
7.698E-1
 1 1
11 ctd:D014215 Triacetin CTD 3.065E-4 3.054E-2
2.568E-1
7.698E-1
 1 1
12 CID000173566 delta-N-methylarginine Stitch 3.065E-4 3.054E-2
2.568E-1
7.698E-1
 1 1
13 CID000069256 gallamide Stitch 3.065E-4 3.054E-2
2.568E-1
7.698E-1
 1 1
14 ctd:D002211 Capsaicin CTD 3.259E-4 3.054E-2
2.568E-1
8.188E-1
 3 492
15 ctd:D010938 Plant Oils CTD 3.338E-4 3.054E-2
2.568E-1
8.385E-1
 3 496
16 CID000003199 NSC648766 Stitch 3.399E-4 3.054E-2
2.568E-1
8.537E-1
 2 93
17 ctd:C039060 dihydroartemisinin CTD 3.928E-4 3.054E-2
2.568E-1
9.868E-1
 2 100
18 CID000444218 AC1L9FY1 Stitch 4.007E-4 3.054E-2
2.568E-1
1.000E0
 2 101
19 CID000007537 tri-tert-butylaluminum Stitch 6.129E-4 3.054E-2
2.568E-1
1.000E0
 1 2
20 CID005287936 1y2g Stitch 6.525E-4 3.054E-2
2.568E-1
1.000E0
 2 129
21 CID000015979 pristane Stitch 9.039E-4 3.054E-2
2.568E-1
1.000E0
 2 152
22 ctd:D002715 Chlormadinone Acetate CTD 9.192E-4 3.054E-2
2.568E-1
1.000E0
 1 3
23 ctd:D001580 Benzopyrenes CTD 9.192E-4 3.054E-2
2.568E-1
1.000E0
 1 3
24 ctd:C115945 rhododendrol CTD 9.192E-4 3.054E-2
2.568E-1
1.000E0
 1 3
25 5275 UP Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.001E-3 3.054E-2
2.568E-1
1.000E0
 2 160
26 4404 UP Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.001E-3 3.054E-2
2.568E-1
1.000E0
 2 160
27 5364 UP Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.001E-3 3.054E-2
2.568E-1
1.000E0
 2 160
28 ctd:D020148 Butyric Acid CTD 1.013E-3 3.054E-2
2.568E-1
1.000E0
 2 161
29 2658 UP Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.026E-3 3.054E-2
2.568E-1
1.000E0
 2 162
30 3771 UP Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.026E-3 3.054E-2
2.568E-1
1.000E0
 2 162
31 3963 UP Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.051E-3 3.054E-2
2.568E-1
1.000E0
 2 164
32 3770 UP Helveticoside [630-64-8]; Up 200; 7.4uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.064E-3 3.054E-2
2.568E-1
1.000E0
 2 165
33 3290 UP Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.076E-3 3.054E-2
2.568E-1
1.000E0
 2 166
34 5826 UP Strophanthidin [66-28-4]; Up 200; 9.8uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.076E-3 3.054E-2
2.568E-1
1.000E0
 2 166
35 5324 UP Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.076E-3 3.054E-2
2.568E-1
1.000E0
 2 166
36 4801 UP Digitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.089E-3 3.054E-2
2.568E-1
1.000E0
 2 167
37 6680 UP Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.089E-3 3.054E-2
2.568E-1
1.000E0
 2 167
38 6724 UP Digoxin [20830-75-5]; Up 200; 5.2uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.115E-3 3.054E-2
2.568E-1
1.000E0
 2 169
39 CID000446755 P-NE Stitch 1.115E-3 3.054E-2
2.568E-1
1.000E0
 2 169
40 1132 UP BW-B 70C; Up 200; 31.6uM; MCF7; HT HG-U133A EA Broad Institute CMAP Up 1.115E-3 3.054E-2
2.568E-1
1.000E0
 2 169
41 965 UP felodipine; Up 200; 10uM; MCF7; HT HG-U133A EA Broad Institute CMAP Up 1.128E-3 3.054E-2
2.568E-1
1.000E0
 2 170
42 4680 UP Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.128E-3 3.054E-2
2.568E-1
1.000E0
 2 170
43 7063 UP MG-262; Up 200; 0.1uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.128E-3 3.054E-2
2.568E-1
1.000E0
 2 170
44 5247 UP Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.142E-3 3.054E-2
2.568E-1
1.000E0
 2 171
45 5026 UP Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.142E-3 3.054E-2
2.568E-1
1.000E0
 2 171
46 1998 UP Niclosamide [50-65-7]; Up 200; 12.2uM; HL60; HG-U133A Broad Institute CMAP Up 1.155E-3 3.054E-2
2.568E-1
1.000E0
 2 172
47 4617 UP Thonzonium bromide [553-08-2]; Up 200; 6.8uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.168E-3 3.054E-2
2.568E-1
1.000E0
 2 173
48 CID000000773 histidinate Stitch 1.182E-3 3.054E-2
2.568E-1
1.000E0
 2 174
49 3267 UP Cyclosporin A [59865-13-3]; Up 200; 3.4uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.195E-3 3.054E-2
2.568E-1
1.000E0
 2 175
50 869 UP wortmannin; Up 200; 1uM; MCF7; HT HG-U133A EA Broad Institute CMAP Up 1.195E-3 3.054E-2
2.568E-1
1.000E0
 2 175
Show 45 more annotations

18: Disease [Display Chart] 7 input genes in category / 230 annotations before applied cutoff / 16205 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 C0206634 Liposarcoma, Myxoid DisGeNET Curated 5.625E-7 6.469E-5 3.893E-4 1.294E-4 3 42
2 C0545074 Myxoid/Round Cell Liposarcoma DisGeNET BeFree 5.625E-7 6.469E-5 3.893E-4 1.294E-4 3 42
3 C0544886 Somatic mutation DisGeNET Curated 1.846E-6 1.416E-4 8.518E-4 4.247E-4 3 62
4 C0678128 Friend leukemia DisGeNET BeFree 5.750E-6 3.306E-4 1.989E-3 1.322E-3 2 9
5 C1266127 Histiocytoma, Angiomatoid Fibrous DisGeNET Curated 1.245E-5 5.726E-4 3.446E-3 2.863E-3 2 13
6 C0023827 liposarcoma DisGeNET Curated 1.725E-5 6.611E-4 3.978E-3 3.967E-3 3 130
7 C0085669 Acute leukemia DisGeNET Curated 2.710E-5 8.904E-4 5.358E-3 6.233E-3 4 491
8 C1275278 Extraskeletal Myxoid Chondrosarcoma DisGeNET Curated 5.585E-5 1.591E-3 9.574E-3 1.285E-2 2 27
9 C0017160 Gastroenteritis DisGeNET Curated 6.458E-5 1.591E-3 9.574E-3 1.485E-2 2 29
10 C0796070 MICROPHTHALMIA, SYNDROMIC 7 DisGeNET Curated 6.918E-5 1.591E-3 9.574E-3 1.591E-2 2 30
11 C0206651 Sarcoma, Clear Cell DisGeNET Curated 1.116E-4 2.334E-3 1.404E-2 2.567E-2 2 38
12 C1298180 Single tumor DisGeNET BeFree 1.713E-4 3.283E-3 1.976E-2 3.940E-2 2 47
13 C0553580 Ewings sarcoma DisGeNET Curated 3.333E-4 5.520E-3 3.321E-2
7.667E-2
 3 352
14 OMIN:613488 MYXOID LIPOSARCOMA OMIM 4.320E-4 5.520E-3 3.321E-2
9.935E-2
 1 1
15 cv:C0206634 Myxoid liposarcoma Clinical Variations 4.320E-4 5.520E-3 3.321E-2
9.935E-2
 1 1
16 OMIN:612219 EWING SARCOMA; ES OMIM 4.320E-4 5.520E-3 3.321E-2
9.935E-2
 1 1
17 C1377916 Benign vascular neoplasm DisGeNET BeFree 4.320E-4 5.520E-3 3.321E-2
9.935E-2
 1 1
18 cv:C0553580 Ewing's sarcoma Clinical Variations 4.320E-4 5.520E-3 3.321E-2
9.935E-2
 1 1
19 cv:CN030217 Epithelial-myoepithelial carcinoma Clinical Variations 8.638E-4 7.358E-3 4.428E-2
1.987E-1
 1 2
20 C0206631 Lipomatous neoplasm DisGeNET BeFree 8.638E-4 7.358E-3 4.428E-2
1.987E-1
 1 2
21 C4025698 Abnormality of the peritoneum DisGeNET Curated 8.638E-4 7.358E-3 4.428E-2
1.987E-1
 1 2
22 C2930974 Acute erythroleukemia DisGeNET BeFree 8.638E-4 7.358E-3 4.428E-2
1.987E-1
 1 2
23 C0346117 Malignant Lipomatous Neoplasm DisGeNET BeFree 8.638E-4 7.358E-3 4.428E-2
1.987E-1
 1 2
24 C0684354 Benign neoplasm of sweat gland DisGeNET BeFree 8.638E-4 7.358E-3 4.428E-2
1.987E-1
 1 2
25 C1332578 Haemangioma of bone DisGeNET BeFree 8.638E-4 7.358E-3 4.428E-2
1.987E-1
 1 2
26 C0854866 Non-Hodgkin's lymphoma recurrent DisGeNET BeFree 8.638E-4 7.358E-3 4.428E-2
1.987E-1
 1 2
27 C0019522 Adenoma, Sweat Gland DisGeNET BeFree 8.638E-4 7.358E-3 4.428E-2
1.987E-1
 1 2
28 C4024608 Necrotizing myopathy DisGeNET BeFree 1.295E-3 9.611E-3
5.783E-2
2.979E-1
 1 3
29 C0334509 Clear cell sarcoma, of tendons and aponeuroses DisGeNET BeFree 1.295E-3 9.611E-3
5.783E-2
2.979E-1
 1 3
30 C1334419 Low Grade Sarcoma DisGeNET BeFree 1.295E-3 9.611E-3
5.783E-2
2.979E-1
 1 3
31 OMIN:612237 CHONDROSARCOMA, EXTRASKELETAL MYXOID OMIM 1.295E-3 9.611E-3
5.783E-2
2.979E-1
 1 3
32 C0206671 Eccrine acrospiroma DisGeNET BeFree 1.727E-3 1.135E-2
6.829E-2
3.972E-1
 1 4
33 C0559460 Adrenal neuroblastoma DisGeNET BeFree 1.727E-3 1.135E-2
6.829E-2
3.972E-1
 1 4
34 C1096335 myeloradiculopathy DisGeNET BeFree 1.727E-3 1.135E-2
6.829E-2
3.972E-1
 1 4
35 C1266065 Eccrine porocarcinoma DisGeNET BeFree 1.727E-3 1.135E-2
6.829E-2
3.972E-1
 1 4
36 C1367554 Adamantinoma DisGeNET BeFree 2.158E-3 1.379E-2
8.297E-2
4.964E-1
 1 5
37 C0751690 Malignant Peripheral Nerve Sheath Tumor DisGeNET Curated 2.539E-3 1.567E-2
9.431E-2
5.839E-1
 2 182
38 C0334699 Malignant myoepithelioma DisGeNET BeFree 2.589E-3 1.567E-2
9.431E-2
5.956E-1
 1 6
39 C0334551 Myxoid chondrosarcoma DisGeNET BeFree 3.020E-3 1.654E-2
9.951E-2
6.947E-1
 1 7
40 C0279980 Extraosseous Ewings sarcoma-primitive neuroepithelial tumor DisGeNET Curated 3.020E-3 1.654E-2
9.951E-2
6.947E-1
 1 7
41 C0343363 Viral gastroenteritis due to Rotavirus DisGeNET BeFree 3.020E-3 1.654E-2
9.951E-2
6.947E-1
 1 7
42 C0003872 Arthritis, Psoriatic DisGeNET Curated 3.026E-3 1.654E-2
9.951E-2
6.959E-1
 2 199
43 C0039101 synovial sarcoma DisGeNET Curated 3.300E-3 1.654E-2
9.951E-2
7.590E-1
 2 208
44 C1333295 Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma DisGeNET BeFree 3.451E-3 1.654E-2
9.951E-2
7.938E-1
 1 8
45 C1710026 Sclerosing Epithelioid Fibrosarcoma DisGeNET BeFree 3.451E-3 1.654E-2
9.951E-2
7.938E-1
 1 8
46 C1266099 Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation DisGeNET BeFree 3.451E-3 1.654E-2
9.951E-2
7.938E-1
 1 8
47 C1334956 Neuroepithelial, Perineurial, and Schwann Cell Neoplasm DisGeNET BeFree 3.451E-3 1.654E-2
9.951E-2
7.938E-1
 1 8
48 C0279622 Small cell osteosarcoma DisGeNET BeFree 3.451E-3 1.654E-2
9.951E-2
7.938E-1
 1 8
49 C1843792 FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED DisGeNET Curated 3.882E-3 1.732E-2
1.042E-1
8.928E-1
 1 9
50 C1275282 Low-grade fibromyxoid sarcoma DisGeNET BeFree 3.882E-3 1.732E-2
1.042E-1
8.928E-1
 1 9
Show 45 more annotations